<DOC>
	<DOCNO>NCT01403324</DOCNO>
	<brief_summary>Metastases thyroid cancer iodine uptake treat repeated activity I-131 administer thyroid hormone withdrawal . The goal thyroid hormone withdrawal treat patient elevate thyrotropin stimulate hormone ( TSH ) , hormone secrete pituitary , gland locate brain . Another way obtain elevated TSH level perform intramuscular injection recombinant human TSH , hormone produce pharmaceutically . The goal study know whether radioiodine uptake metastasis similar rhTSH administration thyroid hormone withdrawal .</brief_summary>
	<brief_title>Comparison Dosimetry After rhTSH Withdrawal Thyroid Hormone Metastatic Locally Advanced Thyroid Cancer</brief_title>
	<detailed_description>Patients undergo rhTSH stimulation , stay thyroid hormone treatment . Following 2 administration rhTSH injection I-124 perform . Positron emission tomography compute tomography scan ( PET/CT ) , blood test , measurement whole body radioactivity occur 4 96 hour follow I-124 administration order perform dosimetry ( i.e . ) estimate radiation dose deliver metastasis . After 4 week thyroid hormone patient undergo thyroid hormone withdrawal new administration I-124 perform . The dosimetry study realize PET/CT , blood test , measurement whole body radioactivity . A therapeutic activity I-131will administer followed whole body scan realize 24 72 hour administration I-131 . Dosimetry study compare order determine whether rhTSH stimulation replace thyroid hormone withdrawal treatment distant metastasis .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Patients thyroid cancer know measurable ( &gt; 1cm ) distant metastases demonstrate radioiodine uptake previous whole body scan 2 . Patients plan therapeutic activity 131I thyroid hormone withdrawal 3 . Age &gt; 18 year 4 . Previous treatment radioiodine 6 month inclusion . 5 . Serum TSH level &lt; 0.5 mU/L 6 . Normal renal function creatinine clearance estimation use CockcroftGault formula &gt; 60 ml/ml 7 . Effective mean contraception female patient , risk pregnancy 8 . Written inform consent 1 . Patients whose majority tumoral lesion disclose FDG uptake without radioactive iodine uptake 2 . Iodine excess ( &lt; 50 Î¼g/dl ) 3 . Large diffuse bone brain metastases 4 . Patients multiple small tumor focus le 1 cm diameter , miliary spread lung 5 . Patients already include therapeutic trial experimental medicine 6 . Pregnancy breast feeding patient 7 . Subject kind disorder compromise ability subject give write informed consent and/or comply study procedures 8 . Treatment antivitamin k</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>metastatic locally advanced differentiate thyroid cancer</keyword>
	<keyword>plan therapeutic activity 131I thyroid hormone withdrawal</keyword>
</DOC>